United Capital Financial Advisers, LLC Biomarin Pharmaceutical Inc Transaction History
United Capital Financial Advisers, LLC
- $11.5 Billion
- Q2 2024
A detailed history of United Capital Financial Advisers, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, United Capital Financial Advisers, LLC holds 4,742 shares of BMRN stock, worth $329,616. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,742
Previous 6,150
22.89%
Holding current value
$329,616
Previous $537,000
27.37%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding BMRN
# of Institutions
632Shares Held
185MCall Options Held
1.63MPut Options Held
1.2M-
Black Rock Inc. New York, NY22.7MShares$1.58 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.32 Billion0.03% of portfolio
-
Primecap Management CO Pasadena, CA18.8MShares$1.31 Billion1.14% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$968 Million0.72% of portfolio
-
Capital Research Global Investors Los Angeles, CA9.69MShares$674 Million0.18% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $12.9B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...